6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.

Sign in
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
Journal article   Open access   Peer reviewed

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

Beate Kampmann, Shabir A. Madhi, Iona Munjal, Eric A.F. Simões, Barbara A. Pahud, Conrado Llapur, Jeffrey Baker, Gonzalo Pérez Marc, David Radley, Emma Shittu, …
The New England journal of medicine, Vol.388(16), pp.1451-1464
20/04/2023
Handle:
https://hdl.handle.net/10523/21587

Abstract

Childhood Diseases Global Health Gynecology Gynecology General Infectious Disease Infectious Disease General Neonatology Obstetrics Pediatrics Pediatrics General Vaccines Viral Infections
Maternal vaccination was 82% effective in preventing medically attended RSV-associated lower respiratory tract illness in infants within 90 days after birth and 69% effective within 180 days.
url
https://doi.org/10.1056/NEJMoa2216480View
Published (Version of record)All Rights Reserved Open

Details

Logo image